Clinical details of patients on commencement of therapy
| Synbiotic (8 starting patients) | Placebo (8 starting patients) | |
|---|---|---|
| Values are mean (range) or number. | ||
| *Disease extent unknown for one placebo patient. | ||
| †Ulcerative colitis related drugs only. | ||
| CRP, C reactive protein. | ||
| Age (y) | 45 (24–66) | 38 (26–59) |
| Sex (M:F) | 3:5 | 5:3 |
| Duration of disease (y) | 10 (1–23) | 7 (1–15) |
| Disease extent* | ||
| Total | 3 | 2 |
| Left sided | 4 | 3 |
| Proctosigmoid | 1 | 2 |
| Current drugs† | ||
| Steroids | 5 | 5 |
| Immunosupressants | 6 | 6 |
| 5-ASA | 5 | 5 |
| Initial clinical activity index | 5.6 (2–13) | 4.7 (1–8) |
| Initial sigmoidoscopy score | 4.4 (2.5–6.0) | 2.9 (0–6) |
| Initial CRP (mg/l) | 6.0 (0–16) | 5.5 (0–17) |